Institutional
M28 Capital Management LP
CIK 0001807489
$53.8M
Reported AUM
9
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · M28 Capital Management LP · Q1 2026
AI · grounded in 13F
M28 Capital Management LP reduced its position in TGTX by 45.3255%. The fund also trimmed holdings in RCKT and ARWR, both by 45.3249%. In total, the fund reduced seven of its nine positions without adding any new holdings to its $53.79 million portfolio.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | WVE | WAVE LIFE SCIENCES LTD | $33.3M | 61.83% | -1,076,264 | -19.0% |
| 2 | IVVD | INVIVYD INC | $12.0M | 22.35% | — | HELD |
| 3 | TGTX | TG THERAPEUTICS INC | $2.9M | 5.46% | -73,246 | -45.3% |
| 4 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $2.3M | 4.29% | -30,549 | -45.3% |
| 5 | PRQR | PROQR THRAPEUTICS N V | $972K | 1.81% | -419,705 | -41.2% |
| 6 | GUTS | FRACTYL HEALTH INC | $850K | 1.58% | — | HELD |
| 7 | RCKT | ROCKET PHARMACEUTICALS INC | $755K | 1.40% | -174,809 | -45.3% |
| 8 | SLN | SILENCE THERAPEUTICS PLC | $533K | 0.99% | -83,897 | -45.3% |
| 9 | CRIS | CURIS INC | $156K | 0.29% | -236,170 | -45.3% |
Source: SEC EDGAR · accession 0000902664-26-002442. 13F discloses long positions only — shorts, foreign equities, and options are excluded.